Immunohistochemistry Applied to Breast Cytological Material
Pathobiology · 2022 · 89 (5) · 343-358
DOI: 10.1159/000522542 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathobiology, online erschienen am 01.04.2022. Verfasst von Daniel Pinto und 1 weiteren Autor:innen. Beteiligte Einrichtung: Serviço de Anatomia Patológica, Centro Hospitalar de Lisboa Ocidental, EPE, Lisboa, Portugal. Hauptthemen laut MEDLINE: Breast Neoplasms, Cytodiagnosis. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 83 Literaturangaben.
Abstract (Originalsprache)
Fine-needle aspiration biopsies (FNABs) of the breast are minimally invasive procedures enabling the diagnosis of suspicious breast lesions. Unfortunately, they are often perceived as inferior to core-needle biopsies, namely because they are supposedly unable to differentiate between high-grade ductal carcinoma in situ and invasive carcinoma or provide material for ancillary testing. Several studies have shown, however, that FNAB samples, when handled properly, are indeed capable of providing sufficient and adequate material for ancillary testing, namely immunocytochemistry (ICC). We reviewed the published literature regarding the use of ICC for both diagnostic and theranostic uses in the different types of cytological samples obtained from FNABs of the breast, including smears, liquid-based cytology samples, and cellblocks. We found that p63 and 34βE12 show promise in aiding in the differential diagnosis between in situ and invasive lesions and that most other diagnostic markers may be used as in tissue. Regarding theranostic ICC markers, results vary between publications, but with care, these can successfully be performed in cytological samples. Air-dried smears should be avoided, and cellblocks are overall more versatile than cytology slides, enabling the evaluation of not only hormonal receptors and HER2 by ICC, but also of Ki-67. Particular attention should be paid to fixation and antigen retrieval procedures in all cases. We recommend that laboratories without experience perform short validation runs before adopting these techniques into clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Serviço de Anatomia Patológica, Centro Hospitalar de Lisboa Ocidental, EPE, Lisboa, Portugal.
- NOVA Medical School, Lisboa, Portugal.
- IPATIMUP-Instituto de Patologia e Imunologia Molecular da Universidade do Porto, Porto, Portugal.
- Faculdade de Medicina da Universidade do Porto, Porto, Portugal.
- RISE (Health Research Network) @ CINTESIS (Center for Health Technology and Services Research), Porto, Portugal.
Zitieren
APA
Pinto, D., & Schmitt, F. C. (2022). Immunohistochemistry Applied to Breast Cytological Material. Pathobiology, 89(5), 343-358. https://doi.org/10.1159/000522542
Vancouver
Pinto D, Schmitt FC. Immunohistochemistry Applied to Breast Cytological Material. Pathobiology. 2022;89(5):343-358. doi:10.1159/000522542
BibTeX
@article{Pinto2022,
author = {Pinto, Daniel and Schmitt, Fernando C},
title = {Immunohistochemistry Applied to Breast Cytological Material},
journal = {Pathobiology},
year = {2022},
volume = {89},
number = {5},
pages = {343--358},
doi = {10.1159/000522542}
}
EUVIMED